首页 > 会议日程详情
2025-06-14 星期六
16:00-16:40 【B座-4层-402】

Session IV
主持人

李磊 

唐勇 

王建宁 

姚旭东 

EV-302: Updated analysis from the phase 3 global study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC)
软件融合机器人辅助靶向、系统性与认知融合手动靶向前列腺活检的诊断性能比较——基于167例回顾性分析
Development and Clinical Validation of a Urine-Based DNA Methylation Assay for Noninvasive Detection of Prostate Cancer A Prospective Study
TALAPRO-2研究中他拉唑帕利联合恩扎卢胺一线治疗转移性去势抵抗性前列腺癌患者的最终总生存